Combination Treatment Extends Survival in Advanced Bladder Cancer - News Center
Immunotherapy combined with chemotherapy and surgery significantly improves survival in muscle-invasive bladder cancer patients compared to chemotherapy alone.
Half of advanced melanoma patients live for 10 years with double drug treatment
The introduction of combined immunotherapy has drastically improved survival rates for patients with advanced melanoma.
Combination Treatment Extends Survival in Advanced Bladder Cancer - News Center
Immunotherapy combined with chemotherapy and surgery significantly improves survival in muscle-invasive bladder cancer patients compared to chemotherapy alone.
Half of advanced melanoma patients live for 10 years with double drug treatment
The introduction of combined immunotherapy has drastically improved survival rates for patients with advanced melanoma.
Breast cancer survival not boosted by double mastectomy, study says
Women who had a mastectomy and kept their other breast did just as well as those who had a double mastectomy for breast cancer.
There is no survival advantage to having the other breast removed, according to a study of over 661,000 women with breast cancer.
For women with BRCA1 or BRCA2 gene variants, considering a double mastectomy may be beneficial due to increased cancer risk.
Trial results for new lung cancer drug are off the charts', say doctors
A new drug, lorlatinib, has shown unprecedented success in stopping lung cancer progression, leading to a longer survival rate compared to standard treatment.